Acetylon Pharmaceuticals

About:

Acetylon Pharmaceuticals manufactures small molecule drugs to realize the therapeutic potential of histone deacetylase.

Top Investors: The Kraft Group, Celgene, Cobro Ventures

Description:

Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.

Total Funding Amount:

$151M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)acetylon.com

Founders:

Jay Bradner, Ken Anderson, Marc Cohen, Ralph Mazitschek

Number of Employees:

1-10

Last Funding Date:

2013-07-29

IPO Status:

Private

Industries: